Navigation Links
Marijuana ineffective as an Alzheimer's treatment: UBC-Vancouver Coastal Health research
Date:2/8/2010

The benefits of marijuana in tempering or reversing the effects of Alzheimer's disease have been challenged in a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.

The findings, published in the current issue of the journal Current Alzheimer Research, could lower expectations about the benefits of medical marijuana in combating various cognitive diseases and help redirect future research to more promising therapeutics.

Previous studies using animal models showed that HU210, a synthetic form of the compounds found in marijuana, reduced the toxicity of plaques and promoted the growth of new neurons. Those studies used rats carrying amyloid protein, the toxin that forms plaques in the brains of Alzheimer's victims.

The new study, led by Dr. Weihong Song, Canada Research Chair in Alzheimer's Disease and a professor of psychiatry in the UBC Faculty of Medicine, was the first to test those findings using mice carrying human genetic mutations that cause Alzheimer's disease widely considered to be a more accurate model for the disease in humans.

"As scientists, we begin every study hoping to be able to confirm beneficial effects of potential therapies, and we hoped to confirm this for the use of medical marijuana in treating Alzheimer's disease," says Song, a member of the Brain Research Centre at UBC and VCH Research Institute and Director of Townsend Family Laboratories at UBC.

"But we didn't see any benefit at all. Instead, our study pointed to some detrimental effects."

Over a period of several weeks, some of the Alzheimer's-afflicted mice were given varying doses of HU210 also known as cannabinoids which is 100 to 800 times more potent than the marijuana compounds. Their memory was then tested.

The mice treated with HU210 did no better than untreated mice, with those given low doses of HU210 performing the worst. The researchers also found that HU210-treated mice had just as much plaque formation and the same density of neurons as the control group. The group given higher doses actually had fewer brain cells.

"Our study shows that HU210 has no biological or behavioural effect on the established Alzheimer's disease model," says Song, the Jack Brown and Family Professor and Chair in Alzheimer's Disease. "More studies should be done before we place much hope in marijuana's benefits for Alzheimer's patients."


'/>"/>

Contact: Hilary Thomson
hilary.thomson@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related medicine news :

1. 215 Agenda Medical Marijuana Collective Located in Lake Forest, CA, has Donated $1,500 to Friends of the El Toro Library
2. Medical Marijuana Super Store Opens in East Oakland
3. Marijuana Compounds Could Beat Back Brain Cancer
4. Marijuana Munchies May Be Rooted in Biology
5. Teen Marijuana Use Might Have Lasting Effects on Mood, Anxiety
6. Pot and pop: New research finds stronger link between music and marijuana use among teens
7. Marijuana, Alcohol Addiction May Share Genes
8. Marijuana Use No Longer Dropping Among U.S. Teens
9. Medithrive Voted #1 Medicinal Marijuana Dispensary in Bay Area
10. Review Finds Marijuana May Help MS Patients
11. Parental Monitoring Can Curb Teen Marijuana Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... DDS, and Randall Markarian, DDS, are co-chairs for the Illinois State Dental Society ... Friday-Saturday, July 15-16 at the Gateway Convention Center in Collinsville. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... Foundation, a not-for-profit organization responsible for clinical transfusion research programs and for the ... the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , ...
(Date:6/23/2016)... ... June 23, 2016 , ... SyncDog, Inc. ... mobile security software, is featured in the current issue of Silicon Review ... companies with innovative technology solutions and features them in their magazine. The magazine ...
(Date:6/23/2016)... Newark, NJ (PRWEB) , ... June 23, 2016 ... ... declared today’s Appellate Court ruling a victory for consumers seeking relief from the ... Div., Docket No. A2913-15T2 & A2929-15T2. , In their ruling ( ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... A key ... DC area, which is one of the best known examples of areas that lack ... amassed almost a thousand daily users. , Any participant within the marijuana industry, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Consumers have taken a more ... placed more emphasis on patient outcomes. ... in the pharmaceutical industry have evolved beyond just ... companies are focusing on becoming more patient-oriented across ... and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, Inc., ... development and manufacturing of collagen and mineral based ... today that Bill Messer has joined ... to further leverage the growing portfolio of oral ... Bill joins the Collagen Matrix executive ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
Breaking Medicine Technology: